Judge approves $7.25bn settlement for Roundup weedkiller cancer claims
Also reported by The Hill, Guardian World, PBS NewsHour
Summary
A Missouri judge approved Bayer’s $7.25 billion settlement for claims that its Roundup weedkiller caused non-Hodgkin lymphoma. The settlement provides payments to eligible people who are already sick and those diagnosed in the future, while Bayer continues to deny that Roundup causes cancer.Key Facts
- Judge Timothy Boyer called the settlement fair, reasonable, and adequate.
- Eligible claimants may receive between $10,000 and $165,000, depending on factors including product use, diagnosis date, and illness severity.
- Bayer will make annual payments into a fund for up to 21 years, with total payments of as much as $7.25 billion.
- Some attorneys objected that the proposed funds were insufficient.
- Bayer has already paid roughly $10 billion to resolve Roundup-related litigation.
- The Supreme Court ruled in June in Bayer’s favor in a separate case involving a Missouri man who blamed Roundup for his cancer.
- The International Agency for Research on Cancer classified glyphosate as a probable human carcinogen in 2015; Bayer and some regulators, including the U.S. Environmental Protection Agency, have disputed that finding.
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.